6D Global Technologies, Inc. Lawsuit Details

Gilman Law LLP announces that a class action lawsuit has been filed against 6D Global Technologies, Inc. (“6D Global” or the “Company”)(SIXD) , its alleged controlling shareholder, Benjamin Wei, and certain officers and directors of the Company.

The Complaint was brought on behalf of a class of shareholders of 6D Global or its predecessor, CleanTech Innovations, Inc. (NASDAQ:CTEK), and alleges that the named Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) the Company had deficient internal controls that allowed Benjamin Wei to exert improper influence and control over the Company, (2) the Company was engaged in improper and undisclosed material related party transactions, and (3) Defendants were engaged in a scheme to manipulate the Company’s stock price.

On September 8, 2015, the Department of Justice indicted Wei, the founder of New York Global Group, for securities fraud. On September 10, 2015, the Securities and Exchange Commission filed a civil action against Wei and New York Global Group for their roles in the alleged fraudulent scheme to obtain and profit from undisclosed, controlling ownership interests in several U.S. companies, including 6D Global.

Following these events, NASDAQ halted trading in 6D Global on September 10, 2015.

We are encouraging shareholders who invested in 6D Global and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

Gilman Law LLP, a leading financial law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from securities class actions and derivative actions. For over 35 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.

Contact: Kenneth G. Gilman
kgilman@gilmanlawllp.com

Gilman Law LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts against ConforMIS, Inc. (“ConforMIS” or the “Company”)(CFMS) and certain of its officers for alleged violations of the federal securities laws under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1940 (the “Exchange Act”).

The Complaint was brought on behalf of a class of shareholders who purchased ConforMIS common stock pursuant to the Company’s Registration Statement and Prospectus issued in connection with the Company’s initial public offering (“IPO”) on or about July 1, 2015, or on the open market between July 1, 2015 and August 28, 2015, and alleges that the Defendants made false and/or misleading statements, and failed to disclose material adverse facts regarding the Company’s business, operational and compliance policies in connection with the IPO and in filings with the SEC. Specifically, the Complaint asserts that the Defendants violated the Securities Act and the Exchange Act by making false and/or misleading statements and/or failing to disclose that: (i) the Company’s manufacturing processes were flawed; (ii) as a result of the flaws in the Company’s manufacturing process, a number of the Company’s knee replacement product systems were defective; and (iii) as a result of the foregoing, ConforMIS’ public statements were materially false and misleading.

ConforMIS, headquartered in Bedford, Massachusetts, is a medical technology company that develops, manufactures, and sells customized joint replacement implants.

If you are an investor who purchased ConforMIS common stock pursuant to or in connection with the IPO or thereafter until August 28, 2015, and suffered a loss then please contact Gilman Law LLP today, at 1-888-252-0048 or www.investment-losses.com, to ensure your legal rights are not forfeited.

About Gilman Law LLP

Gilman Law LLP, a leading financial law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from securities class actions and derivative actions. For over 35 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.

Contact: Kenneth G. Gilman

1-888-252-0048

Receptos, Inc. and Celgene, Corp. Lawsuit Details – Celgene Corporation’s Proposed Buyout

Gilman Law LLP announced that a complaint on was filed on July 20, 2015 on behalf of a shareholder of Receptos, Inc. (NASDAQ: RCPT) seeking to block Celgene’s proposed $7.2 billion buyout and for breach of fiduciary duty by accepting an offer that undervalued the company’s stock when the company was about to have tremendous growth.

The complaint explains, under the proposed buyout, Receptos agreed not to continue discussion with other potential buyers and give Celgene four business days to match a competing proposal. Receptos also agreed to pay Celgene a $240 million termination fee if the company sold to a higher bidder. The plaintiff states these points made it nearly impossible for Receptos to shop for possible higher bidders. The complaint went on to explain that the Receptos’ drug, Ozanimod-used to treat relapsing multiple sclerosis and irritable bowel disorder, is in late-stage trials which analyst estimate could be worth $5 billion. Considering this, Wedbush Securities raised its target price for Receptos stock from $211 to $408 in June, 2015. Under the proposed buyout, Celgene is offering $240 per share. The complaint alleges the shareholders will not be given a fair portion of Receptos’ assets.

We are encouraging shareholders who invested in Receptos Inc. and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

LRR Energy LP Lawsuit Details – Vanguard Natural Resources LLC Merger

Gilman Law LLP announced that a complaint on was filed on July 10, 2015 on behalf of shareholders of LRR Energy LP (NASDAQ: LRE) for possible breaches of fiduciary duty in connection with its acquisition by Vanguard Natural Resources.

The complaint claims the offer to acquire LRR Energy for $251 million in Vanguard common units is inadequate and does not take into consideration LRR Energy’s current performance and probable growth. The complaint also contends that the Board eliminated negotiations with other potential bidders when it agreed to a “no shop” provision which included a $7.3 million termination fee. The complaint further alleges LRR Energy’s SEC registration statement was inaccurate and that the company agreed to acquire Eagle Rock Energy Partners LLP for $614 million, causing the shareholders to have a smaller percentage of ownership in Vanguard.

We are encouraging shareholders who invested in LRR Energy LP and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Broadcom Corporation Lawsuit Details – Avago Technologies Ltd. Merger

Gilman Law LLP announced that a complaint on was filed on June 18, 2015 on behalf of shareholders of Broadcom Corporation (NASDAQ: BRCM) for possible breaches of fiduciary duty in connection with its merger its rival Avago Technologies Ltd. The complaint claims the proposed merger and offer to acquire Broadcom for $37 billion is inadequate and will leave the common stockholders “shortchanged”. The complaint also alleges those in control of the company stand to benefit the most and the cash-and-stock deal only offers a 16% premium to Broadcom’s closing price.

We are encouraging shareholders who invested in Broadcom Corporation and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.